How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,502 results for

Fetal Tachycardia

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. The Relationship Between Fetal Baseline Heart-rate and the Level of Acetyl-choline Esterase in Fetal Blood

beats per minute and 140-160 beats per minute. Criteria Inclusion Criteria: Pregnant women between 32 and 41 weeks` gestation undergoing either vaginal or cesarean delivery with a fetal baseline heart rate of 110-130 beats per minute and 140-160 beats per minute. Exclusion Criteria: Delivery before 32 weeks of gestation Maternal bradycardic (<60) or tachycardic (>100) resting heart rate. Fetal bradycardia (<110) or tachycardia (>160). Suspected chorioamnionitis Maternal diseases which can affect her (...) The Relationship Between Fetal Baseline Heart-rate and the Level of Acetyl-choline Esterase in Fetal Blood The Relationship Between Fetal Baseline Heart-rate and the Level of Acetyl-choline Esterase in Fetal Blood - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100

2018 Clinical Trials

22. Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcomes. (Abstract)

; perinatal mortality; fetal hypoxia; fetal tachycardia) or on any of the reviews neonatal or maternal outcomes.There is insufficient evidence to confirm or refute the effectiveness of caffeine avoidance on birthweight or other pregnancy outcomes. There is a need to conduct high-quality, double-blinded RCTs to determine whether caffeine has any effect on pregnancy outcome. (...) Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcomes. Maternal caffeine consumption during pregnancy may have adverse effects on fetal, neonatal and maternal outcomes.This review investigates the effects of restricting caffeine intake by mothers on fetal, neonatal and pregnancy outcomes.We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (16 January 2015), scanned bibliographies of published studies and corresponded

2015 Cochrane

23. Successful fluoroless radiofrequency catheter ablation of supraventricular tachycardia during pregnancy Full Text available with Trip Pro

Successful fluoroless radiofrequency catheter ablation of supraventricular tachycardia during pregnancy Even in the absence of underlying heart disease, pregnancy is known to increase susceptibility supraventricular tachycardia (SVT). This brings a management challenge, mainly due to concerns about pharmacotherapy and radiation to the fetus. This case highlights the capability of using fluoroless mapping technologies to treat refractory arrhythmia cases safely and successful.

2018 Clinical Case Reports

24. The effect of intrapartum oxygen supplementation on Category II fetal monitoring. (Abstract)

The effect of intrapartum oxygen supplementation on Category II fetal monitoring. Maternal oxygen (O2) administration for Category II electronic fetal monitoring (EFM) is a widely used intrauterine resuscitation technique, despite a paucity of evidence on its ability to improve EFM patterns. We investigated the effect of intrapartum O2 administration on Category II EFM patterns.This is a secondary analysis of a randomized trial conducted from 2016-2017, in which patients ≥ 37 weeks in active (...) labor with Category II EFM were assigned to 10 L/min O2 by facemask or room air (RA) until delivery. Trained obstetric research nurses blinded to allocation extracted EFM data. The primary outcome was a composite of high-risk Category II features including recurrent variable decelerations, recurrent late decelerations, prolonged decelerations, tachycardia or minimal variability 60 minutes after randomization to RA or O2. Secondary outcomes included individual components of the composite, resolution

2020 American Journal of Obstetrics and Gynecology

25. Concurrent maternal and fetal tachyarrhythmia in pregnancy Full Text available with Trip Pro

Concurrent maternal and fetal tachyarrhythmia in pregnancy The occurrence of a maternal and fetal tachyarrhythmia together in pregnancy is exceedingly rare. We report a case of a persistent fetal atrial ectopic tachycardia occurring in conjunction with a maternal atrial tachycardia with left ventricular systolic dysfunction. Amiodarone was effective in treating both maternal and fetal arrhythmias.

2017 Obstetric medicine

26. Is Intravenous Adenosine Effective and Safe in Patients presenting with Unstable Paroxysmal Supraventricular Tachycardia?

Is Intravenous Adenosine Effective and Safe in Patients presenting with Unstable Paroxysmal Supraventricular Tachycardia? BestBets: Is Intravenous Adenosine Effective and Safe in Patients presenting with Unstable Paroxysmal Supraventricular Tachycardia? Is Intravenous Adenosine Effective and Safe in Patients presenting with Unstable Paroxysmal Supraventricular Tachycardia? Report By: Dr.Adnan Gebril - StR in Emergency Medicine Search checked by Dr.Stephen Hawes - Consultant in Emergency (...) Medicine Institution: University Hospital of South Manchester Foundation NHS Trust Date Submitted: 1st March 2000 Date Completed: 23rd February 2012 Last Modified: 23rd February 2012 Status: Green (complete) Three Part Question In [patients with Unstable Paroxysmal Supraventricular Tachycardia] is [treatment with intravenous Adenosine] both [effective and safe]? Clinical Scenario A 40-year-old woman with known paroxysmal supraventricular tachycardia (PSVT) presents to the emergency department

2012 BestBETS

27. Usefulness of Routine Transtelephonic Monitoring for Supraventricular Tachycardia in Infants. (Abstract)

Usefulness of Routine Transtelephonic Monitoring for Supraventricular Tachycardia in Infants. We hypothesize that routine daily transtelephonic monitoring (TTM) transmissions can accurately detect supraventricular tachycardia (SVT) in asymptomatic infants and/or assuage parental concerns rather than being used solely to diagnose arrhythmias.Single center, retrospective chart review of 60 patients with fetal or infant SVT prescribed TTM for at least 30 days, January 2010-September 2016. Patients (...) were excluded if initial SVT was not documented, was perioperative, was atrial flutter/fibrillation, or chaotic atrial tachycardia. Categorical variables expressed as mean ± SD. Mann-Whitney, Spearman correlation, and Fisher exact tests were used for continuous and categorical variables respectively.Sixty patients were included. There were 2688 TTM transmissions received from 55 of 60 patients over 61.1 ± 66.7 days (0.73 ± 0.65 TTM/patient/days). Routine asymptomatic TTM transmissions revealed

2017 Journal of Pediatrics

28. Left ventricular non-compaction cardiomyopathy with coronary artery anomaly complicated by ventricular tachycardia. Full Text available with Trip Pro

Left ventricular non-compaction cardiomyopathy with coronary artery anomaly complicated by ventricular tachycardia. Non-compaction cardiomyopathy (NCCM) is characterized by prominent trabeculations, deep intertrabecular recesses, and a thick non-compacted endocardial myocardium. Prevalence in the general population remains unclear, but echocardiography series report 0.05%. During fetal development muscle fibers and trabeculae should compact into a solid myocardium and when this fails, NCCM (...) 35% despite optimal pharmacological therapy, an implantable cardioverter defibrillator (ICD) was implanted and four years later a ventricular tachycardia was terminated by antitachycardia pacing.We describe a case of NCCM with a concomitant coronary anomaly, in which systolic myocardial dysfunction developed. The ICD subsequently terminated a life-threatening ventricular arrhythmia, which supports risk stratification based on low ejection fraction and possibly coronary anomaly.

2017 BMC Cardiovascular Disorders

29. Prenatal diagnosis and management of junctional ectopic tachycardia Full Text available with Trip Pro

Department of Medical Physics, University of Wisconsin, Biomagnetism Laboratory, Wisconsin Institutes for Medical Research, Madison, Wisconsin. eng Case Reports 2017 08 30 United States HeartRhythm Case Rep 101656239 2214-0271 Electrocardiography Fetal echocardiography Fetal magnetocardiography Fetal tachycardia Fetal treatment Fetus Hydrops fetalis Junctional ectopic tachycardia 2018 2 2 6 0 2018 2 2 6 0 2018 2 2 6 1 epublish 29387539 10.1016/j.hrcr.2017.07.022 S2214-0271(17)30148-3 PMC5778096 Prenat (...) Prenatal diagnosis and management of junctional ectopic tachycardia 29387539 2019 02 26 2214-0271 3 11 2017 Nov HeartRhythm case reports HeartRhythm Case Rep Prenatal diagnosis and management of junctional ectopic tachycardia. 503-508 10.1016/j.hrcr.2017.07.022 Zaidi S Javed SJ The Heart Institute for Children, Advocate Children's Hospital, Oak Lawn, Illinois. Siddiqui Saad S The Heart Institute for Children, Advocate Children's Hospital, Oak Lawn, Illinois. Rosalind Franklin School of Medicine

2017 HeartRhythm Case Reports

30. Intraoperative Three-Dimensional Mapping of Supraventricular Tachycardia in a Young Fontan Patient. Full Text available with Trip Pro

Intraoperative Three-Dimensional Mapping of Supraventricular Tachycardia in a Young Fontan Patient. Preoperative tachycardia is uncommon before an initial Fontan procedure. Catheter intervention can risk complications in small patients. A patient with fetal tachycardia and double inlet left ventricle underwent Norwood and bidirectional Glenn procedures. She had persistent tachycardia. A three-dimensional electroanatomic mapping system was modified for the operative procedure; it was used (...) to identify the arrhythmia substrate and cryoablate an atrioventricular nodal tachycardia. Mapping added 20 minutes to the operation. She is arrhythmia-free and off medication after 4 months. This three-dimensional system was successfully adapted for an intraoperative SVT ablation in this small patient, and it may be useful in other settings.Copyright © 2017 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

2017 Annals of Thoracic Surgery

31. Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial. (Abstract)

Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial. Standardized treatment of fetal tachyarrhythmia has not been established.This study sought to evaluate the safety and efficacy of protocol-defined transplacental treatment for fetal supraventricular tachycardia (SVT) and atrial flutter (AFL).In this multicenter, single-arm trial, protocol-defined transplacental treatment using digoxin, sotalol, and flecainide was performed for singleton pregnancies from 22 to <37 (...)  weeks of gestation with sustained fetal SVT or AFL ≥180 beats/min. The primary endpoint was resolution of fetal tachyarrhythmia. Secondary endpoints were fetal death, pre-term birth, and neonatal arrhythmia. Adverse events (AEs) were also assessed.A total of 50 patients were enrolled at 15 institutions in Japan from 2010 to 2017; short ventriculoatrial (VA) SVT (n = 17), long VA SVT (n = 4), and AFL (n = 29). One patient with AFL was excluded because of withdrawal of consent. Fetal tachyarrhythmia

2019 Journal of the American College of Cardiology Controlled trial quality: uncertain

32. Lack of fetal effect from adenosine administration in a pregnant patient. (Abstract)

Lack of fetal effect from adenosine administration in a pregnant patient. Supraventricular Tachycardias are the most common cardiac rhythm disturbances in pregnant patients. Adenosine is the recommended medication to treat these arrhythmias in part because the medication is projected to be metabolized prior to crossing the placenta and producing any fetal effects. Reported here is a case of a pregnant patient treated with adenosine in which the fetal heart activity was monitored through point (...) of care ultrasonography with documentation of no fetal impact from this medication. This is the first documentation of a lack of fetal effect from adenosine.Copyright © 2019 Elsevier Inc. All rights reserved.

2019 American Journal of Emergency Medicine

33. Fetal dysrhythmias. Full Text available with Trip Pro

Fetal dysrhythmias. Fetal dysrhythmias are common abnormalities, usually manifesting as irregular rhythms. Although most irregularities are benign and caused by isolated atrial ectopics, in a few cases, rhythm irregularity may indicate partial atrioventricular block, which has different etiological and prognostic implications. We provide a flowchart for the initial management of irregular rhythm to help select cases requiring urgent specialist referral. Tachycardias and bradycardias are less (...) frequent, can lead to hemodynamic compromise, and may require in utero therapy. Pharmacological treatment of tachycardia depends on the type (supraventricular tachycardia or atrial flutter) and presence of hydrops, with digoxin, flecainide, and sotalol being commonly used. An ongoing randomized trial may best inform about their efficacy. Bradycardia due to blocked bigeminy normally resolves spontaneously, but if it is due to established complete heart block, there is no effective treatment. Ongoing

2019 Best practice & research. Clinical obstetrics & gynaecology

34. Fetal hyperthyroidism associated with maternal thyroid autoantibodies: A case report Full Text available with Trip Pro

Fetal hyperthyroidism associated with maternal thyroid autoantibodies: A case report A 33-year-old Caucasian woman was referred at 24 + 3 weeks of gestation due to fetal tachycardia and hydrops. She had an uncomplicated pregnancy 16 years previously and was on levothyroxine after total thyroidectomy for Graves' disease 6 years previously, when she developed moderate exophthalmos. Laboratory evaluation revealed appropriate thyroid function for this time of gestation: thyroid stimulating hormone (...) (TSH) 1.7 μU/ml (1-3), fT4 18.53 pmol/l (12-22), with positive antibodies: anti-TPO 157 U/ml (<35), TSH receptor antibodies (TRAb) 171.95 U/l (<1.75). The diagnosis was fetal hyperthyroidism due to transplacental passage of stimulating maternal TRAb. Methimazole and digoxin were initiated. The patient remained euthyroid, with fT4 levels in the upper normal range. The fetus showed intrauterine growth retardation, oligohydramnios, aggravating hydrops, goiter with increased central vascularization

2018 Case Reports in Women's Health

35. Diagnosis and Treatment of Fetal Cardiac Disease Full Text available with Trip Pro

function Irregular rhythm 0.3% with CHD;2% with arrhythmia (0-0.7) I/C (frequent)IIa/C (persistent > 1-2 wks) At detection1–2 wk after detection Baseline fetal echocardiography and if persistent weekly heart rate monitoring until resolved to assess for tachycardia Noncardiac abnormality 20–45 I/B At detection Risk depends on organ systems affected ( ) Known or suspected chromosomal abnormality Varies, may be as high as 90 I/C 12–14 wk and/or 18–22 wk See the Extracardiac Assessment of the Fetus (...) of fetus (maternal, paternal or sibling with CHD) First or second degree relative with disorder with Mendelian inheritance with CHD association Fetal cardiac abnormality suspected on obstetrical ultrasound Fetal extracardiac abnormality suspected on obstetrical ultrasound Fetal karyotype abnormality Fetal tachycardia or bradycardia, or frequent or persistent irregular heart rhythm Fetal increased NT >95% (≥3 mm) Monochorionic twinning Fetal hydrops or effusions Indications with lower risk profile

2014 American Heart Association

36. Fetal Tachycardia

Tachycardia , FHR Tachycardia From Related Chapters II. Definition >160 bpm III. Mild Fetal Tachycardia (FHR 160-180 bpm) Usually benign if normal Other causes Maternal fever, dehydration or anxiety Maternal ketosis Medications s (e.g. ) medications (e.g. ) Fetal movement Preterm Fetus Maternal Maternal IV. Significant Fetal Tachycardia (FHR >180 bpm) (especially if maternal fever) Fetal arrhythmia or congenital defect (FHR >200 bpm) V. References Bailey (2000) ALSO, E:1-13 Gabbe (2002) Obstetrics, p. 395 (...) foetale tachycardie , tachycardiie, foetaal , tachycardie foetaal German fetale Tachykardie , Tachykardie fetal Japanese 胎児頻脈 , タイジヒンミャク English fetal tachycardia (diagnosis) , fetal tachycardia , Tachycardia fetal , Foetal tachycardia , Tachycardia foetal , Fetal Tachycardia , Baseline Fetal Tachycardia , Fetal tachycardia , Fetal tachycardia (disorder) Czech Tachykardie u plodu , Fetální tachykardie Hungarian Tachycardia, foetalis , Magzati tachycardia , Foetalis tachycardia , Magzati szapora

2015 FP Notebook

37. Fetal Long QT Syndrome Manifested as Atrioventricular Block and Ventricular Tachycardia: A Case Report and a Review of the Literature. (Abstract)

Fetal Long QT Syndrome Manifested as Atrioventricular Block and Ventricular Tachycardia: A Case Report and a Review of the Literature. Fetal onset of congenital long QT syndrome (LQTS) is a rare manifestation, and prenatal diagnosis is difficult. This report describes a boy who presented with both atrioventricular (AV) block and ventricular tachycardia during the antenatal period. The early postnatal electrocardiogram showed prolongation of the QT interval and AV block, subsequently leading (...) to a polymorphic ventricular tachycardia torsade de pointes. This unique feature of congenital LQTS has a poor outcome, but the boy was successfully treated with beta-blockers and implantation of an automated cardioverter-defibrillator. The intrauterine manifestation of fetal AV block and ventricular tachycardia should raise a high suspicion of congenital LQTS, and the strong association with a malignant clinical course should warrant special evaluation. The literature on the prenatal diagnosis, fetal therapy

2012 Pediatric Cardiology

38. AIUM Practice Parameter for the Performance of Fetal Echocardiography

and phenylketonuria); and • Teratogen exposure (eg, retinoids and lithium). 2013—AIUM PRACTICE PARAMETER—Fetal Echocardiography 1 www.aium.org fetalEcho.qxp_1115 12/1/15 3:11 PM Page 1B. Fetal Indications • Abnormal cardiac screening examination; • First-degree relative of a fetus with congenital heart disease; • Abnormal heart rate or rhythm; • Fetal chromosomal anomaly; • Extracardiac anomaly; • Hydrops; • Increased nuchal translucency; and • Monochorionic twins. IV . Written Request for the Examination (...) . A normal fetal heart rate at mid-gestation is 120 to 180 beats per minute. If bradycardia or tachycardia is documented, or if the rhythm is noted to be irregular, simultaneous assessment of atrial and ventricular contraction should be performed using either simultaneous Doppler sonogra- phy of the mitral inflow–aortic outflow or superior vena cava–ascending aorta or by M-mode sonography of the atrium and ventricle to determine the underlying mechanism. An alternative approach using tissue Doppler

2013 American Institute of Ultrasound in Medicine

39. Antenatal antiarrhythmic treatment for fetal tachyarrhythmias: a study protocol for a prospective multicentre trial. Full Text available with Trip Pro

of this study is to evaluate the efficacy and safety of the protocol-defined transplacental treatment of fetal tachyarrhythmias. Participant recruitment began in October 2010.The current study is a multicentre, single-arm interventional study. A total of 50 fetuses will be enrolled from 15 Japanese institutions. The protocol-defined transplacental treatment is performed for singletons with sustained fetal tachyarrhythmia ≥180 bpm, with a diagnosis of supraventricular tachycardia or atrial flutter. Digoxin (...) Antenatal antiarrhythmic treatment for fetal tachyarrhythmias: a study protocol for a prospective multicentre trial. Several retrospective or single-centre studies demonstrated the efficacy of transplacental treatment of fetal tachyarrhythmias. Our retrospective nationwide survey showed that the fetal therapy will be successful at an overall rate of 90%. For fetuses with hydrops, the treatment success rate will be 80%. However, standard protocol has not been established. The objective

2017 BMJ open

40. Fetal neonatal hyperthyroidism: diagnostic and therapeutic approachment Full Text available with Trip Pro

Fetal neonatal hyperthyroidism: diagnostic and therapeutic approachment Fetal and neonatal hyperthyroidism may occur in mothers with Graves' disease. Fetal thyrotoxicosis manifestation is observed with the transition of TSH receptor stimulating antibodies to the fetus from the 17th-20th weeks of pregnancy and with the fetal TSH receptors becoming responsive after 20 weeks. The diagnosis is confirmed by fetal tachycardia, goiter and bone age advancement in pregnancy and maternal treatment (...) is conducted in accordance. The probability of neonatal hyperthyroidism is high in the babies of mothers that have ongoing antithyroid requirement and higher antibody levels in the last months of pregnancy. Clinical manifestation may be delayed by 7-17 days because of the antithyroid drugs taken by the mother. Neonatal hyperthyroidism symptoms can be confused with sepsis and congenital viral infections. Herein, the diagnosis and therapeutic approach are reviewed in cases of fetal neonatal hyperthyroidism.

2017 Turkish Archives of Pediatrics/Türk Pediatri Arşivi

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>